"Find your cardiologist in Dayton at Premier Cardiovascular Institute's Dayton location. Our cardiologists treat a wide range of heart-related conditions on an inpatient and outpatient basis. Our highly trained specialists are experienced in the diagnosis and treatment of cardiac conditions and preventive care. At Premier Cardiovascular Institute, our focus is on supporting your health as well as treating you when you’re ill. rd-certified physicians are skilled in cardiovascular disease, echocardiography, electrophysiology, endovascular intervention, heart care, interventional cardiology, valve disease, and vascular disease. Premier Cardiology Institute has convenient offices so you have easy access to the high-quality, advanced cardiac care"

During the past decade, Premier Cardiovascular Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Premier Cardiovascular Institute" are "Cardiovascular Disease" (2 trials), "Artery Diseases, Peripheral" (1 trials), "Atherosclerosis" (1 trials), "Heart Failure" (1 trials) and "Occlusive Arterial Disease" (1 trials). Many other conditions were trialed in "Premier Cardiovascular Institute" in a lesser frequency.

Most popular intervention types in "Premier Cardiovascular Institute" are "Device" (3 trials), "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device." (1 trials), "BiovitalsHF" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Premier Cardiovascular Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Premier Cardiovascular Institute". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Premier Cardiovascular Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Premier Cardiovascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".